EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation

Maor Bril, Ashraf Imam, Elchanan Parnasa, Michael Rivin, Suha Shabaneh, Keren Tzukert, Abel Roai, Offer Amir iD, Abed Khalaileh, Rabea Asleh iD

ESC Heart Failure · 2026

DOI: 10.1093/eschf/xvag221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Maor Bril und 9 weiteren Autor:innen. Beteiligte Einrichtung: Heart Institute, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, P.O.B 12000, Jerusalem 91112001, Israel. Hauptthemen laut MEDLINE: Heart Failure, Kidney Transplantation, Stroke Volume, Ventricular Function, Left. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Heart failure (HF) drives post-kidney transplant (KT) morbidity. While KT reverses components of uraemic cardiomyopathy, the persistence of post-transplant risk in HF with preserved (HFpEF) versus HF with reduced ejection fraction (HFrEF) remains unclear. We evaluated phenotype-specific remodelling and clinical outcomes.

Methods

Retrospective cohort of adult KT recipients stratified by pre-transplant echocardiography: HFpEF (left ventricular ejection fraction [LVEF] ≥50% with elevated filling pressures), HFrEF (LVEF <50%), or controls. Longitudinal echocardiographic remodelling and post-transplant outcomes were analysed using multivariable Cox regression.

Results

Of 442 recipients, 64 (14.5%) had HFpEF, 44 (10.0%) HFrEF, and 334 (75.5%) controls. Over a 49-month median follow-up, HFpEF was independently associated with HF hospitalization (adjusted hazard ratio [aHR] 9.57; 95% confidence interval [CI] 3.37–27.2, P < .001) and composite death/HF hospitalization (aHR 4.46; 95% CI 2.36–8.42, P < .001). Paired longitudinal echocardiography demonstrated persistent diastolic stiffness within the HFpEF group (E/e': 12.7 ± 4.6 to 11.8 ± 5.3, P = .117). Conversely, HFrEF patients exhibited systolic recovery (ΔLVEF +8.7 ± 10.2%, P = .003), remaining independently associated with all-cause mortality (aHR 2.9; 95% CI 1.16–7.25, P = .023) but not HF hospitalization (aHR 3.11; 95% CI 0.71–13.6, P = .13). Mechanistically, ΔLVEF predicted lower HF hospitalization risk (aHR 0.94; 95% CI 0.90–0.99, P = .02), whereas mortality tracked with continuous changes in haemoglobin (aHR 0.71; 95% CI 0.60–0.83, P < .001) and calcium (aHR 0.69; 95% CI 0.50–0.96, P = .027).

Conclusions

Post-KT trajectories differ by pre-transplant HF phenotype. Uraemic HFpEF is a persistent, non-reversible phenotype driving severe post-KT morbidity. HFrEF demonstrates systolic reversibility. Pre-transplant evaluation should incorporate targeted diastolic profiling beyond standard LVEF-centred assessment to identify KT candidates at high risk for recurrent post-transplant HF morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureKidney TransplantationStroke VolumeVentricular Function, LeftVentricular RemodelingKidney Failure, ChronicHumansRetrospective StudiesPrognosisFemaleMaleEchocardiographyPhenotypeMiddle AgedFollow-Up Studies

Stichwörter der Autor:innen

Cardiac remodellingHFpEFHFrEFHeart failureKidney transplantationUraemic cardiomyopathy

Autor:innen und Institutionen

  • Heart Institute, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, P.O.B 12000, Jerusalem 91112001, Israel.
  • Department of General Surgery and Organ Transplantation Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, P.O.B 12000, Jerusalem 91112001, Israel.
  • Department of Nephrology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, P.O.B 12000, Jerusalem 91112001, Israel.

ORCID-Profile: Offer Amir, Rabea Asleh

Zitieren

APA

Bril, M., Imam, A., Parnasa, E., Rivin, M., Shabaneh, S., Tzukert, K., Roai, A., Amir, O., Khalaileh, A., & Asleh, R. (2026). Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag221

Vancouver

Bril M, Imam A, Parnasa E, Rivin M, Shabaneh S, Tzukert K, et al. Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag221

BibTeX
@article{Bril2026,
  author = {Bril, Maor and Imam, Ashraf and Parnasa, Elchanan and Rivin, Michael and Shabaneh, Suha and Tzukert, Keren and Roai, Abel and Amir, Offer and Khalaileh, Abed and Asleh, Rabea},
  title = {Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag221}
}
Kostenlos starten →